Drugs / Emblica officinalis
Emblica officinalis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07688005 | Sep → Nov 2026 expected | periapical periodontitis | Postgraduate Medical Institute, Lahore | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Emblica officinalis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07688005 ↗ |
| Action | Inhibit | “Several in vitro studies have demonstrated significant antibacterial activity of Emblica officinalis against Enterococcus faecalis.” NCT07688005 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Emblica officinalis (Amla) is a medicinal plant with well-documented antibacterial, anti-inflammatory, antioxidant, and analgesic properties. It has been widely used in...” NCT07688005 ↗ |